The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions
Linda M Collins, Susan A Murphy, Victor Strecher, Linda M Collins, Susan A Murphy, Victor Strecher
Abstract
In this article two new methods for building and evaluating eHealth interventions are described. The first is the Multiphase Optimization Strategy (MOST). It consists of a screening phase, in which intervention components are efficiently identified for inclusion in an intervention or for rejection, based on their performance; a refining phase, in which the selected components are fine tuned and issues such as optimal levels of each component are investigated; and a confirming phase, in which the optimized intervention, consisting of the selected components delivered at optimal levels, is evaluated in a standard randomized controlled trial. The second is the Sequential Multiple Assignment Randomized Trial (SMART), which is an innovative research design especially suited for building time-varying adaptive interventions. A SMART trial can be used to identify the best tailoring variables and decision rules for an adaptive intervention empirically. Both the MOST and SMART approaches use randomized experimentation to enable valid inferences. When properly implemented, these approaches will lead to the development of more potent eHealth interventions.
Figures

Source: PubMed
Připravované klinické studie
-
Magnus MedicalCongressionally Directed Medical Research ProgramsNábor
-
Nicholas ButowskiSiren BiotechnologyZatím nenabírámeGliom | Novotvar mozku | Opakující se gliomy vysokého stupněSpojené státy
-
State University of New York at BuffaloZatím nenabírámeZapojení pacientaSpojené státy
-
Poitiers University HospitalZatím nenabíráme
-
Assistance Publique - Hôpitaux de ParisZatím nenabírámeSrpkovitá anémie | Vasookluzivní krize
-
University of California, IrvineNáborRakovina mozku | Rakovina CNS | Rakovina nervového systému | Metastatický nádor mozkuSpojené státy
-
Qualia Life SciencesNábor
-
Guangdong Raynovent Biotech Co., LtdZatím nenabíráme
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationNáborDospělí | Digitální asistence při nízkém vidění | Zrakové postiženíHongkong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Zatím nenabírámeDuktální adenokarcinom slinivky břišní (PDAC)
-
Sun Yat-sen UniversityZatím nenabírámeOdvykání kouření | Agent AI | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityZatím nenabíráme